Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiake Xu

Showing results (231-240 of 401) with videos related to

Pageof 41
Sort By:
Bioactive Materials|October 2, 2020
Inhibition of furin by bone targeting superparamagnetic iron oxide nanoparticles alleviated breast cancer bone metastasisYichuan Pang, Li Su, Yao Fu, et al.
Stem Cell Research|February 27, 2019
Generation of induced pluripotent stem cell line, ZJUCHi002-A, from Charcot-Marie-Tooth disease type 2A (CMT2A) patient with a mutation of c.752C>T in MFN2Jiake Xu, Yong Fu, Weichun Xia, et al.
Bone Research|June 16, 2025
Pathophysiology of Myopenia in rheumatoid arthritisHaiming Jin, Gang Wang, Qichen Lu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 28, 2025
Network pharmacology and in-depth blood proteomics reveal the mechanism of Buqi Tongluo capsules in treating bone destruction in osteoarthritisHaishan Li, Jiasheng Yang, Wei Deng, et al.
International Immunopharmacology|November 3, 2022
AKT/GSK3β/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosisShuyue Yang, Dezhi Song, Ziyi Wang, et al.
Analytical Chemistry|October 3, 2022
Subcellular Partitioning of Arsenic Trioxide Revealed by Label-Free ImagingSong Huang, Kai Chen, Jong-Kai Leung, et al.
Frontiers in Pharmacology|March 29, 2022
CYT387, a JAK-Specific Inhibitor Impedes Osteoclast Activity and Oophorectomy-Induced Osteoporosis <i>via</i> Modulating RANKL and ROS Signaling PathwaysJing Li, Jiamin Liang, Liwei Wu, et al.
International Immunopharmacology|September 26, 2025
Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone lossHaibo Liang, Qihang Wu, Tianyong Hua, et al.
Theranostics|December 11, 2024
Rc3h1 negatively regulates osteoclastogenesis by limiting energy metabolismLiuyuan Chen, Yuangang Su, Chaofeng Wang, et al.
Journal of Agricultural and Food Chemistry|September 5, 2024
Tetrahydroberberine Prevents Ovariectomy-Induced Bone Loss by Inhibiting RANKL-Induced Osteoclastogenesis and Promoting Osteoclast ApoptosisQihang Wu, Haibo Liang, Chenyu Wang, et al.
Pageof 41

Showing results (231-240 of 401) with videos related to

Sort By:
Pageof 41
Bioactive Materials|October 2, 2020
Inhibition of furin by bone targeting superparamagnetic iron oxide nanoparticles alleviated breast cancer bone metastasisYichuan Pang, Li Su, Yao Fu, et al.
Stem Cell Research|February 27, 2019
Generation of induced pluripotent stem cell line, ZJUCHi002-A, from Charcot-Marie-Tooth disease type 2A (CMT2A) patient with a mutation of c.752C>T in MFN2Jiake Xu, Yong Fu, Weichun Xia, et al.
Bone Research|June 16, 2025
Pathophysiology of Myopenia in rheumatoid arthritisHaiming Jin, Gang Wang, Qichen Lu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 28, 2025
Network pharmacology and in-depth blood proteomics reveal the mechanism of Buqi Tongluo capsules in treating bone destruction in osteoarthritisHaishan Li, Jiasheng Yang, Wei Deng, et al.
International Immunopharmacology|November 3, 2022
AKT/GSK3β/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosisShuyue Yang, Dezhi Song, Ziyi Wang, et al.
Analytical Chemistry|October 3, 2022
Subcellular Partitioning of Arsenic Trioxide Revealed by Label-Free ImagingSong Huang, Kai Chen, Jong-Kai Leung, et al.
Frontiers in Pharmacology|March 29, 2022
CYT387, a JAK-Specific Inhibitor Impedes Osteoclast Activity and Oophorectomy-Induced Osteoporosis <i>via</i> Modulating RANKL and ROS Signaling PathwaysJing Li, Jiamin Liang, Liwei Wu, et al.
International Immunopharmacology|September 26, 2025
Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone lossHaibo Liang, Qihang Wu, Tianyong Hua, et al.
Theranostics|December 11, 2024
Rc3h1 negatively regulates osteoclastogenesis by limiting energy metabolismLiuyuan Chen, Yuangang Su, Chaofeng Wang, et al.
Journal of Agricultural and Food Chemistry|September 5, 2024
Tetrahydroberberine Prevents Ovariectomy-Induced Bone Loss by Inhibiting RANKL-Induced Osteoclastogenesis and Promoting Osteoclast ApoptosisQihang Wu, Haibo Liang, Chenyu Wang, et al.
Pageof 41